Booster doses of mRNA vaccines improve humoral immunogenicity in patients with inflammatory bowel disease

By | December 30, 2021
Researchers evaluated the humoral immunogenicity of a third COVID-19 mRNA vaccine dose in patients with inflammatory bowel disease.